LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses

Kevin D Cook1, Jason K Whitmire2

  • 1Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, NC 27599; and.

Insights

Blockading lymphocyte activation gene-3 (LAG-3) signals may enhance anti-tumor immunity. New research shows LAG-3 expression on CD8(+) T cells intrinsically limits their proliferation, suggesting LAG-3 blockade can boost T cell responses.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Lymphocyte activation gene-3 (LAG-3) is known to inhibit T cell responses.
  • LAG-3 blockade is being investigated in clinical trials to enhance anti-tumor immunity.
  • Previous studies suggested nuanced roles for LAG-3, as LAG-3-deficient mice showed similar T cell responses to wild-type animals.

Purpose of the Study:

  • To investigate the T cell-intrinsic functions of LAG-3 in regulating CD8(+) T cell responses.
  • To elucidate the specific mechanisms by which LAG-3 influences T cell proliferation and fitness.

Main Methods:

  • Adoptive transfer experiments in mouse models.
  • Comparison of T cell responses in LAG-3-deficient and wild-type mice during viral infections.

Main Results:

  • LAG-3 expression on CD8(+) T cells intrinsically inhibits their competitive fitness.
  • LAG-3-expressing CD8(+) T cells exhibited a reduced rate of cell division compared to LAG-3-deficient cells.
  • This cell-intrinsic inhibitory effect of LAG-3 was observed in both acute and chronic viral infections.

Conclusions:

  • LAG-3 directly modulates the size of the CD8(+) T cell response.
  • Targeting LAG-3 through blockade regimens holds promise for enhancing CD8(+) T cell-mediated immunity against tumors and infections.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.1K